two drugs that treat different indications but essentially have the same mechanism of action in humans.
- NYR targets calcium ion channels all over the body including the brain hence why it protects the heart in strokes and heart attacks
-AGN targets glutamate which stops production of calcium release in the brain
AGN has a chance to fail due to the target on glutamate is also important for survival of neurons in the brain hence why I sold out of AGN. NYR avoids this but AGN should get solid results because of NA-1
Ann: Notice of Change of Interests of Substantial Holder - M Azzi, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $62.22M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.0¢ | 29.5¢ | $5.511K | 18.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25386 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 149596 | 9 |
View Market Depth
| Last trade - 10.23am 16/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |